Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Small Pharma Inc
V.DMT
Healthcare
Small Pharma Inc. is a biotechnology company focused on short-duration psychedelic therapies for mental health conditions. The Company is focused on developing short-duration psychedelic-assisted therapies for the treatment of mental health conditions that are scalable, commercially differentiated, and conveniently dosed, with the goal of addressing key unmet needs in the treatment of...
depression. It has a portfolio of clinical-stage dimethyltryptamine (DMT)-based assets, SPL026 and SPL028. It has a pipeline of proprietary preclinical assets. Its clinical-stage program, SPL026, a first-generation DMT molecule, has shown proof-of-concept for the potential treatment of MDD. In a Phase IIa study, IV SPL026 demonstrated a rapid and durable antidepressant effect, as well as a favorable safety and tolerability profile. Small Pharma is also advancing SPL028, a second-generation injectable deuterated DMT molecule, in a Phase I trial.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (TSXV:DMT)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
3
4
Next
(100)
•••
GillRipper
X
View Profile
View Bullboard History
Comment by
GillRipper
on Aug 25, 2022 5:06pm
RE:Peter Rands buys 96,000 shares of DMT for $0.18 each
Insider trading activity looks good! Managed to accumulate a few hundred thousand sheets over the past month. (.16 av) Wonder when they'll begin dipping into the market, (share buyback). Nice
...more
(502)
•••
TrevorAbes
X
View Profile
View Bullboard History
Post by
TrevorAbes
on Aug 18, 2022 4:41pm
DMT announces NCIB
https://themarketherald.ca/small-pharma-announces-tsxv-approval-of-normal-course-issuer-bid-2022-08-18/
Voyageur Signs Letter of Intent with Large Multinational Pharmaceutical Company
posted Dec 22, 2024 9:00am by
Voyageur Pharmaceuticals Ltd
-
|
Voyageur is securing supply chains in North America for barium, iodine and fullerene drug development and is aiming to gain efficiencies in production of contrast media products. The company anticipates this LOI will expand Voyageur’s project portfolio and diversify the Company’s product mix. The global contrast media market is valued at $6.3 billion with GE HealthCare projecting it will double over the next decade. ...read more
(1863)
•••
Zaphod
X
View Profile
View Bullboard History
Comment by
Zaphod
on Apr 05, 2022 9:07pm
RE:Some recent insider transactions for Small Pharma Inc.
Thanks there's something on sedar about his ex wife getting 1.8 million shares. The volume is usually 400,000 it was 2.5 million today.. wtf.. I'm sitting at a break even with 200,000
...more
(1863)
•••
Zaphod
X
View Profile
View Bullboard History
Post by
Zaphod
on Apr 05, 2022 12:51pm
sedar....oh damn
So I went to sedar and there is months of daily notices involving auditors , lawyers ex wife, osc , restated financials,.. new shares etc unless I'm missing something this should have been
...more
(1863)
•••
Zaphod
X
View Profile
View Bullboard History
Post by
Zaphod
on Apr 05, 2022 11:52am
any ideas why this is down the toilet
It's got good analyst ratings at 2 to 3 and it's trading now at $0.17. Did I miss the arrest of the entire staff and directors? Did the president bring a machine gun and slaughter the entire
...more
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Sep 20, 2021 6:58pm
Included in AdvisorShares® Newly Launched Psychedelics ETF
LONDON, Sept. 20, 2021 (GLOBE NEWSWIRE) -- Small Pharma Inc. (TSXV: DMT) (the “Company” or “Small Pharma”), a neuropharmaceutical company focused on psychedelic-assisted therapies, announces today
...more
(3018)
•••
Betteryear2
X
View Profile
View Bullboard History
Post by
Betteryear2
on Jul 30, 2021 6:49pm
First Fiscal Quarter 2021 Highlights
Successful completion of listing on TSX Venture Exchange $58 million financing enables potential rapid advancement of Small Pharma’s patent portfolio LONDON, United Kingdom, July 30, 2021 (GLOBE
...more
(75)
•••
raven16
X
View Profile
View Bullboard History
Post by
raven16
on Jun 23, 2021 1:11am
This Is Going To The Moon After Merger. EOM
Prev
1
2
3
4
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
The Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Introducing the NEW DealRoom: Your Gateway to Capital-Raising Investments